Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To determine the benefits and harms of Y-90 microsphere radioembolisation either as a monotherapy or in combination with other systemic or locoregional therapies versus placebo, no treatment, or other similar systemic or locoregional therapies for patients with unresectable hepatocellular carcinoma.